Please use this identifier to cite or link to this item:
Title: PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics.
Austin Authors: Eapen, Renu S ;Nzenza, Tatenda C ;Murphy, Declan G;Hofman, M S;Cooperberg, M;Lawrentschuk, Nathan
Affiliation: Department of Molecular Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia
Department of Urology, Austin Health, Heidelberg, Victoria, Australia
Young Urology Researchers Organisation (YURO), Melbourne, Australia
Department of Urology, Helen Diller Comprehensive Cancer Centre, University of California, San Francisco, USA
Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Jul-2019 2018-10-29
Publication information: World Journal of Urology 2019; 37(7): 1255-1261
Abstract: The heterogeneity of prostate cancer has made imaging modalities of crucial importance in this disease. Accurate diagnosis and staging of the volume and extent of disease, especially in advanced and metastatic prostate cancer, can help to tailor the timing and modalities of treatment. While MRI has been effective in the detection of significant prostate cancer, its use in the identification and quantification of extraprostatic disease is limited. This gap is now being filled by PSMA PET. PSMA PET scans have now been shown to have a role in all stages in the prostate cancer journey. Emerging evidence has shown its promise in primary staging, restaging and theranostics. In this paper, we review the evidence for the use of PSMA PET in the various stages of prostate cancer, from initial diagnosis to advanced metastatic disease where other systemic treatments have failed.
DOI: 10.1007/s00345-018-2524-z
ORCID: 0000-0001-8553-5618
PubMed URL: 30374609
Type: Journal Article
Subjects: Lutetium
Prostate cancer
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 28, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.